A white-knuckle ride of open COVID drug discovery

In early 2020, a spontaneous global collaboration came together to design a new, urgent antiviral treatment. There are lessons in what happened next. In early 2020, a spontaneous global collaboration came together to design a new, urgent antiviral treatment. There are lessons in what happened next.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nature (London) 2021-06, Vol.594 (7863), p.330-332
Hauptverfasser:	von Delft, Frank, Calmiano, Mark, Chodera, John, Griffen, Ed, Lee, Alpha, London, Nir, Matviuk, Tatiana, Perry, Ben, Robinson, Matt, von Delft, Annette
Format:	Artikel
Sprache:	eng
Schlagworte:	631/154 631/326/596/4130 692/308 706/648/496 Chemists Collaboration Comment Coronaviruses COVID-19 vaccines Crystal structure Drug discovery Drugs Enzymes Experiments Humanities and Social Sciences Information systems Intellectual property Mass spectrometry Mass spectroscopy Methods multidisciplinary Pandemics Pharmaceutical industry Proteins Science Severe acute respiratory syndrome coronavirus 2
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	In early 2020, a spontaneous global collaboration came together to design a new, urgent antiviral treatment. There are lessons in what happened next. In early 2020, a spontaneous global collaboration came together to design a new, urgent antiviral treatment. There are lessons in what happened next.
ISSN:	0028-0836 1476-4687
DOI:	10.1038/d41586-021-01571-1